Strategic Deals and Investment Moves Influencing the GLP-1 Marketplace | Evaluate
The obesity sector has witnessed robust GLP-1 deal making with pharma companies showing unprecedented appetite for strategic pharma deals.| Evaluate
The obesity sector has witnessed robust GLP-1 deal making with pharma companies showing unprecedented appetite for strategic pharma deals.| Evaluate
The World Preview webinar will include many data highlights from the report as well as discussion of the big themes in the market.| Evaluate
Back from BIO: The Evolving Biotech Investment Landscape| Evaluate
